Publications

5808 Results

FLT3-ITD Mutations Are Prevalent in Older Adults with Acute Myeloid Leukemia (AML) and Significantly Impact Outcome After Intensive Therapy: Analysis of the North American Intergroup E2906 Phase III Trial in Patients Age > 60 Years

Authors
J Foran;X Sun;E Paietta;J Racevskis;D Claxton;H Lazurus;D Arber;Y Zhang;J Rowe;J Godwin;J Altman;A Al-Kali;H Zheng;ER Broun;B Powell;K O'Dwyer;M Tallman;M Litzow;J Pratz;S Luger
Journal / Conference
Blood 132:3995American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E2906

Prognostic impact of insertion site in acute myeloid leukemia with FLT3 internal tandem duplication: results from the RATIFY study (Alliance)

Authors
F Rucker;L Du;T Blatte;J Krzykalla;I Gathmann;RA Larson;F Lo-Coco;S Amadori;T Prior;J Brandwein;F Appelbaum;B Medeiros;M Tallman;J Sierra;E Tiecke;C Pallaud;M Sanz;T de Witte;D Niederwieser;G Ehninger;M Heuser;M Ganser;L Bullinger;C Bloomfield;RM Stone;H Dohner;C Thiede;K Dohner
Journal / Conference
Blood 132:435; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA)
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10603

Comprehensive molecular profiling of FLT3-mutated acute myeloid leukemia (AML) patients treated within the RATIFY trial

Authors
N Jahn;N Panina;L Bullinger;A Dolnick;J Herzig;T Blatte;A Benner;J Krzykalla;I Gathmann;RA Larson;F Lo-Coco;S Amadori;T Prior;J Brandwein;F Appelbaum;B Medeiros;M Tallman;E Tiecke;C Pallaud;G Ehninger;M Heuser;A Ganser;RM Stone;C Thiede;H Dohner;C Bloomfield;K Dohner
Journal / Conference
Blood 132:1534; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10603

RATIFY: Prognostic Impact of FLT3 Tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy

Authors
M Voso;RA Larson;T Prior;G Marcucci;D Jones;J Krauter;M Heuser;S Lavorgna;J Nomdedeu;K Laumann;S Geyer;R Klisovic;A Wei;J Sierra;M Sanz;J Brandwein;T de Witte;JH Jansen;D Niederwieser;F Appelbaum;B Medeiros;M Tallman;R Schlenk;A Ganser;H Serve;G Ehninger;S Amadori;Y Cheng;I Gathmann;E Tiecke;C Thiede;K Dohner;H Dohner;RM Stone;C Bloomfield;F Lo-Coco
Journal / Conference
Blood 132:2668; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/C10603

African-American Patients with Monoclonal Gammopathy Have a Reduced Risk of Transformation to Clinical Myeloma. Results of a Prospective Study SWOG S0120

Authors
M Dhodapkar;R Sexton;A Hoering;B Barlogie;R Orlowski
Journal / Conference
Blood 132:1877; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), poster
Year
2018
Research Committee(s)
Myeloma
Study Number(s)
S0120

Analysis of Accrual Patterns of Adolescent & Young Adult (AYA) Patients to A National Cooperative Research Group Over 25 Years: The SWOG Experience

Authors
MA Lewis;RKH Johnson;C Nichols;D Hershman;J Unger
Journal / Conference
Global Adolescent & Young Adult Cancer Congress (Dec 4-6, 2018, Sydney, Australia), oral presentation
Year
2018
Research Committee(s)
Cancer Care Delivery

A Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL): A Trial of the ECOG-ACRIN Cancer Research Group (E1912)

Authors
T Shanafelt;V Wang;N Kay;C Hanson;S O'Brien;J Barrientos;H Erba;R Stone;M Litzow;M Tallman
Journal / Conference
Blood 132:LBA-4; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral
Year
2018
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E1912

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

Authors
M Matejcic;EJ Saunders;T Dadaev;MN Brook;K Wang;X Sheng;A Olama;FR Schumacher;K Govindasami;S Benlloch;S Berndt;D Albanes;S Koutros;K Muir;VL Stevens;SM Gapstur;C Tangen;Z Jarai;DV Conti;CA Haiman
Journal / Conference
Nature Communications Nov 5;9(1):4616
Year
2018
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID30397198
PMC
PMC6218483
Study Number(s)
S0000, SWOG-9217

Oregon’s Death With Dignity Act—Reply

Authors
C Blanke;L Ellis;F Meyskens
Journal / Conference
JAMA Oncology 4(5):748
Year
2018
Research Committee(s)
Cancer Care Delivery
PMID
PMID29450455

Acupuncture for Aromatase Inhibitor–Related Joint Pain Among Breast Cancer Patients [Comment and Response]

Authors
DL Hershman;JM Unger;KD Crew
Journal / Conference
JAMA 320(21):2270-2271
Year
2018
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID30512095
Study Number(s)
S1200